Chronic renal failure laboratory tests

Jump to navigation Jump to search

Chronic renal failure Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chronic renal failure from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chronic renal failure laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chronic renal failure laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chronic renal failure laboratory tests

CDC on Chronic renal failure laboratory tests

Chronic renal failure laboratory tests in the news

Blogs on Chronic renal failure laboratory tests

Directions to Hospitals Treating Chronic renal failure

Risk calculators and risk factors for Chronic renal failure laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

Chronic kidney disease is defined as the presence of markers of kidney damage for > 3 months, and may include abnormalities in markers in blood or urine, and imaging test and/or GFR < 60 mL/min/1.73 m2 for > 3 months with or without other signs of kidney damage. The kidneys play an important role in the regulation of serum concentration of electrolytes such as sodium, potassium, calcium, phosphate, bicarbonate and chloride as well as levels of hemoglobin, hematocrit, blood pressure and extracellular volume. Hence, chronic injury to the kidneys can lead to derangement in the normal values of above mentioned parameters.

Urinalysis

Fluid and Electrolyte disturbances

Endocrine and Metabolic disturbances

Hematologic abnormalities

Measurement of Renal Function

Chronic Kidney Disease is defined as:

  • Presence of markers of kidney damage for > 3 months, and may include abnormalities in markers in blood or urine, and imaging tests.
  • GFR < 60 mL/min/1.73 m2 for > 3 months with or without other signs of kidney damage.

Glomerular filtration rates

The stages of CKD is based on the GFR and other renal function abnormalities. The different stages of chronic kidney diseases are as follow:

  • Stage 1: GFR>90 ml/min/1.73m2 and evidence of kidney damage
  • Stage 2: GFR 60-89 ml/min/1.73m2 and evidence of kidney damage
  • Stage 3: GFR 30-59 ml/min/1.73m2
  • Stage 4: GFR 15-29 ml/min/1.73m2
  • Stage 5: GFR <15 ml/min/1.73m2

Serum creatinine

Using serum creatinine alone as an indicator of kidney function may be misleading. This is because the calculated creatinine levels depends on age, gender, race, nutritional status and muscle mass. At GFR levels ≥60 ml/min/1.73 m2, neither the Cockroft and Gault equation nor the MDRD equation provides a reliable measurement of kidney function. The CKD-EPI equation is more accurate than the Cockcroft and Gault equation and the MDRD equation at GFR levels ≥60 ml/min/1.73 m2.


Cystatin C

Cystatin C allows a more precise testing of kidney function than creatinine.[1]

Measurement of urinary neutrophil gelatinase-associated lipocalin (NGAL) can help distinguish chronic kidney disease from acute kidney injury.[2]

Determination of Chronicity

References

  1. Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O; et al. (2012). "Two novel equations to estimate kidney function in persons aged 70 years or older". Ann Intern Med. 157 (7): 471–81. doi:10.7326/0003-4819-157-7-201210020-00003. PMID 23027318.
  2. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N; et al. (2008). "Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury". Ann Intern Med. 148 (11): 810–9. PMC 2909852. PMID 18519927. Review in: ACP J Club. 2008 Dec 16;149(6):13 Review in: Evid Based Med. 2009 Feb;14(1):20


Template:WH Template:WS